Skip to main content
Signal8

EoCene Ltd. (EOCN)

Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.

Sector: Pharmaceutical Preparations

Industry: Medical - Pharmaceuticals

Eocene Ltd. logo

Eocene Ltd.

NASDAQ:EOCNHealthcare
AH+0.00%$2.46
Close$2.46-2.77%
Mkt Cap$2.63M
EV-
Float1.03M
O/S1.07M
VOL10K sh
$ Vol$24K
RVOL1.34×
Inst Own1.4%
SI0.8%
Net Cash/Sh-
Dilution
Eocene Ltd. logoNASDAQ:EOCNAH$2.46+0.00%
Short interest (FINRA)
0.8%
Oct 30 (19d)

Float 1.03M · Signal8 dilution snapshot · Sep 2, 2026

8.4K
Oct 30 (19d)prev 7.5K▲ 11.7%
1.31
Oct 30 (19d)prev 1.00▲ 31.0%
Borrow (IBKR)

The cost to borrow EOCN shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
8.5%
Nov 17 (1d)prev 60.0%▼ 51.5 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

100
Oct 20 (29d)prev 786▼ 87.3%
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Fails to deliver13 settlement dates
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 20268.4K sh
Oct 15, 20267.5K sh
Sep 30, 202614.1K sh
Sep 15, 202611.2K sh
Aug 31, 202619.6K sh
Latest fails to deliver
DateShares failed
Oct 20, 2026100 sh
Oct 14, 2026786 sh
Oct 13, 2026573 sh
Oct 9, 2026650 sh
Oct 5, 2026300 sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 17
Latest sessions
DateReported short
Nov 17, 20268.5%
Nov 16, 202660.0%
Nov 13, 202672.6%
Nov 12, 20262.5%
Nov 11, 202633.2%
48-session median 29.3%mean 33.8%range 1.2–84.0%

130 calendar days requested; 49 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for EOCN: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 8,397 EOCN shares were sold short (0.82% of a 1.03M-share float, 1.31 days to cover).